1. Home
  2. GNLX vs KNDI Comparison

GNLX vs KNDI Comparison

Compare GNLX & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • KNDI
  • Stock Information
  • Founded
  • GNLX 2001
  • KNDI 2002
  • Country
  • GNLX United States
  • KNDI China
  • Employees
  • GNLX N/A
  • KNDI N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • KNDI Auto Manufacturing
  • Sector
  • GNLX Health Care
  • KNDI Consumer Discretionary
  • Exchange
  • GNLX Nasdaq
  • KNDI Nasdaq
  • Market Cap
  • GNLX 112.8M
  • KNDI 96.3M
  • IPO Year
  • GNLX 2023
  • KNDI N/A
  • Fundamental
  • Price
  • GNLX $3.09
  • KNDI $1.13
  • Analyst Decision
  • GNLX Strong Buy
  • KNDI
  • Analyst Count
  • GNLX 4
  • KNDI 0
  • Target Price
  • GNLX $17.75
  • KNDI N/A
  • AVG Volume (30 Days)
  • GNLX 137.5K
  • KNDI 97.2K
  • Earning Date
  • GNLX 08-13-2025
  • KNDI 08-15-2025
  • Dividend Yield
  • GNLX N/A
  • KNDI N/A
  • EPS Growth
  • GNLX N/A
  • KNDI N/A
  • EPS
  • GNLX N/A
  • KNDI N/A
  • Revenue
  • GNLX N/A
  • KNDI $127,569,613.00
  • Revenue This Year
  • GNLX N/A
  • KNDI N/A
  • Revenue Next Year
  • GNLX N/A
  • KNDI N/A
  • P/E Ratio
  • GNLX N/A
  • KNDI N/A
  • Revenue Growth
  • GNLX N/A
  • KNDI 3.21
  • 52 Week Low
  • GNLX $1.60
  • KNDI $0.89
  • 52 Week High
  • GNLX $5.89
  • KNDI $2.12
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 56.10
  • KNDI 51.22
  • Support Level
  • GNLX $2.75
  • KNDI $1.06
  • Resistance Level
  • GNLX $3.17
  • KNDI $1.16
  • Average True Range (ATR)
  • GNLX 0.24
  • KNDI 0.07
  • MACD
  • GNLX -0.00
  • KNDI 0.00
  • Stochastic Oscillator
  • GNLX 56.94
  • KNDI 57.14

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

Share on Social Networks: